Viewing Study NCT05396105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-02-23 @ 8:06 PM
Study NCT ID: NCT05396105
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-09-23
First Post: 2022-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
Sponsor: Pharvaris Netherlands B.V.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hereditary Angioedema View
None Hereditary Angioedema Type I View
None Hereditary Angioedema Type II View
None Hereditary Angioedema Types I and II View
None Hereditary Angioedema Attack View
None Hereditary Angioedema With C1 Esterase Inhibitor Deficiency View
None Hereditary Angioedema - Type 1 View
None Hereditary Angioedema - Type 2 View
None C1 Esterase Inhibitor [C1-INH] Deficiency View
None C1 Esterase Inhibitor Deficiency View
None C1 Esterase Inhibitor, Deficiency of View
None C1 Inhibitor Deficiency View
None Hereditary Angioedema Type III View
None Hereditary Angioedema (HAE) View
None Hereditary Angioedema Type I and II View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HAE View
None HAE Type I View
None HAE Type II View
None Oral Treatment View
None Bradykinin B2 Receptor Antagonists View
None On-Demand View
None PHA121 View
None PHVS416 View
None PHA-022121 View
None Deucrictibant View
None HAE Type III View